Citigroup Lowers Clorox (NYSE:CLX) Price Target to $110.00

Clorox (NYSE:CLXGet Free Report) had its target price reduced by equities research analysts at Citigroup from $115.00 to $110.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. The firm presently has a “neutral” rating on the stock. Citigroup’s price objective points to a potential upside of 6.37% from the company’s previous close.

Other equities analysts also recently issued reports about the company. Barclays dropped their price objective on Clorox from $109.00 to $102.00 and set an “underweight” rating for the company in a research note on Tuesday. UBS Group lowered their target price on Clorox from $121.00 to $110.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Wells Fargo & Company dropped their price target on Clorox from $125.00 to $110.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 8th. BNP Paribas Exane upgraded shares of Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Finally, Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. One investment analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $115.13.

Check Out Our Latest Stock Report on CLX

Clorox Stock Down 1.0%

Shares of NYSE CLX opened at $103.41 on Wednesday. The stock has a market capitalization of $12.50 billion, a price-to-earnings ratio of 17.11, a price-to-earnings-growth ratio of 0.51 and a beta of 0.65. Clorox has a 52 week low of $96.66 and a 52 week high of $143.96. The firm has a 50-day moving average price of $113.75 and a 200 day moving average price of $110.52. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the company posted $1.55 earnings per share. The company’s quarterly revenue was down .8% compared to the same quarter last year. Equities research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Haverford Trust Co grew its holdings in shares of Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after buying an additional 84 shares in the last quarter. Canandaigua National Bank & Trust Co. lifted its stake in shares of Clorox by 0.8% during the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after buying an additional 94 shares during the period. Field & Main Bank boosted its position in Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after acquiring an additional 100 shares during the last quarter. Golden State Wealth Management LLC grew its stake in Clorox by 28.2% in the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after acquiring an additional 100 shares during the period. Finally, Fisher Asset Management LLC raised its holdings in Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after acquiring an additional 102 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.